EE304 A Cost Minimization and Budget Impact Analysis of an Eculizumab Biosimilar, ABP 959, From the Spanish Healthcare Perspective

20250 citationsJournal Article

Authors

Partnerships for the goals

Published in: Value in Health

Volume 28, Issue 6, pp. S118-S118

Field-Weighted Citation Impact: 0.00